Pharmacokinetics of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM or FT-ADM to rats. A new adriamycin analog containing fluorine
References (17)
- et al.
Pharmacokinetics of drugs in blood: III. Metabolism of procainamide and storage effect of blood samples
J. Pharm. Sci.
(1983) New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimens
J. Pharm. Sci.
(1979)- et al.
Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics and pharmacodynamics of furosemide in rats
J. Pharm. Sci.
(1991) Adriamycin — a review
J. Natl. Cancer Inst.
(1975)- et al.
Pharmacokinetics of drugs in blood: VI. Unusual distribution and blood storage effect of bumetanide
Seoul Unit: J. Pharm. Sci.
(1988) Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma concentration-time curve
J. Pharmacokinet. Biopharm.
(1978)- et al.
Pharmacokinetics
(1982) - et al.
Therapeutic activity and tissue distribution of ME2303, a new anthracycline containing fluorine, and its metabolites in mice bearing hepatic metastases of Lewis lung carcinoma
Intr. Cancer Drugs,
(1990)
There are more references available in the full text version of this article.
Cited by (18)
Testicular cytotoxicity of DA-125, a new anthracycline anticancer agent, in rats
1999, Reproductive ToxicologyProdrugs of anticancer agents
1996, Advanced Drug Delivery ReviewsPhase I clinical trial: Pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study
1998, International Journal of Clinical Pharmacology and Therapeutics
Copyright © 1994 Published by Elsevier B.V.